AcouSort AB (publ) (STO:ACOU)

Market Cap	90.37M +29.4%
Revenue (ttm)	10.05M +3.8%
Net Income	-10.50M
EPS	-0.51
Shares Out	21.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,751
Open	4.490
Previous Close	4.440
Day's Range	4.060 - 4.490
52-Week Range	2.030 - 5.160
Beta	0.10
Analysts	n/a
Price Target	11.00 (+157.61%)
Earnings Date	Aug 24, 2026

About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrumen...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 11
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACOU

Financial Performance

In 2025, AcouSort AB's revenue was 10.43 million, an increase of 4.01% compared to the previous year's 10.03 million. Losses were -12.15 million, -19.40% less than in 2024.